Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Endothelial progenitor cells for cardiovascular regeneration.

Literature DB >> 18206807

Endothelial progenitor cells for cardiovascular regeneration.

Abstract

Endothelial progenitor cells (EPCs) are peripheral blood mononuclear cells that can differentiate into mature endothelial cells. Adult EPCs were first discovered in human peripheral blood in 1997. Since then, the potency of EPCs for cardiovascular regeneration has been demonstrated in several preclinical studies; and investigators are beginning to evaluate the therapeutic utility of EPCs in early-phase clinical trials. This review summarizes the progression of basic, preclinical, and clinical research into the potential use of EPC therapy for cardiovascular regeneration.

Entities: Species

Mesh：

Year: 2008 PMID： 18206807 PMCID： PMC2276734 DOI： 10.1016/j.tcm.2007.11.004

Source DB: PubMed Journal: Trends Cardiovasc Med ISSN： 1050-1738 Impact factor: 6.677

44 in total

1. Origins of circulating endothelial cells and endothelial outgrowth from blood.

Authors: Y Lin; D J Weisdorf; A Solovey; R P Hebbel
Journal: J Clin Invest Date: 2000-01 Impact factor: 14.808

2. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells.

Authors: M Gill; S Dias; K Hattori; M L Rivera; D Hicklin; L Witte; L Girardi; R Yurt; H Himel; S Rafii
Journal: Circ Res Date: 2001-02-02 Impact factor: 17.367

3. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia.

Authors: A Kawamoto; H C Gwon; H Iwaguro; J I Yamaguchi; S Uchida; H Masuda; M Silver; H Ma; M Kearney; J M Isner; T Asahara
Journal: Circulation Date: 2001-02-06 Impact factor: 29.690

4. In vitro differentiation of endothelial cells from AC133-positive progenitor cells.

Authors: U M Gehling; S Ergün; U Schumacher; C Wagener; K Pantel; M Otte; G Schuch; P Schafhausen; T Mende; N Kilic; K Kluge; B Schäfer; D K Hossfeld; W Fiedler
Journal: Blood Date: 2000-05-15 Impact factor: 22.113

5. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells.

Authors: E Gunsilius; H C Duba; A L Petzer; C M Kähler; K Grünewald; G Stockhammer; C Gabl; S Dirnhofer; J Clausen; G Gastl
Journal: Lancet Date: 2000-05-13 Impact factor: 79.321

6. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease.

Authors: C Kalka; H Tehrani; B Laudenberg; P R Vale; J M Isner; T Asahara; J F Symes
Journal: Ann Thorac Surg Date: 2000-09 Impact factor: 4.330

7. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects.

Authors: C Kalka; H Masuda; T Takahashi; R Gordon; O Tepper; E Gravereaux; A Pieczek; H Iwaguro; S I Hayashi; J M Isner; T Asahara
Journal: Circ Res Date: 2000-06-23 Impact factor: 17.367

8. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.

Authors: A A Kocher; M D Schuster; M J Szabolcs; S Takuma; D Burkhoff; J Wang; S Homma; N M Edwards; S Itescu
Journal: Nat Med Date: 2001-04 Impact factor: 53.440

9. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.

Authors: Douglas W Losordo; Richard A Schatz; Christopher J White; James E Udelson; Vimal Veereshwarayya; Michelle Durgin; Kian Keong Poh; Robert Weinstein; Marianne Kearney; Muqtada Chaudhry; Aaron Burg; Liz Eaton; Lindsay Heyd; Tina Thorne; Leon Shturman; Peter Hoffmeister; Ken Story; Victor Zak; Douglas Dowling; Jay H Traverse; Rachel E Olson; Janice Flanagan; Donata Sodano; Toshinori Murayama; Atsuhiko Kawamoto; Kengo Fukushima Kusano; Jill Wollins; Frederick Welt; Pinak Shah; Peter Soukas; Takayuki Asahara; Timothy D Henry
Journal: Circulation Date: 2007-06-11 Impact factor: 29.690

10. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.

Authors: C Kalka; H Masuda; T Takahashi; W M Kalka-Moll; M Silver; M Kearney; T Li; J M Isner; T Asahara
Journal: Proc Natl Acad Sci U S A Date: 2000-03-28 Impact factor: 11.205

43 in total

Review 1. Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells.

Authors: Sangho Lee; Young-Sup Yoon
Journal: Br J Pharmacol Date: 2013-05 Impact factor: 8.739

Review 2. Inhibiting vasculogenesis after radiation: a new paradigm to improve local control by radiotherapy.

Authors: Brown J Martin
Journal: Semin Radiat Oncol Date: 2013-10 Impact factor: 5.934

3. TGF-β1 signaling and Krüppel-like factor 10 regulate bone marrow-derived proangiogenic cell differentiation, function, and neovascularization.

Authors: Akm Khyrul Wara; ShiYin Foo; Kevin Croce; Xinghui Sun; Basak Icli; Yevgenia Tesmenitsky; Fehim Esen; Jung-Soo Lee; Malayannan Subramaniam; Thomas C Spelsberg; Eli I Lev; Dorit Leshem-Lev; Reena L Pande; Mark A Creager; Anthony Rosenzweig; Mark W Feinberg
Journal: Blood Date: 2011-08-09 Impact factor: 22.113

4. Bone marrow-derived CMPs and GMPs represent highly functional proangiogenic cells: implications for ischemic cardiovascular disease.

Authors: Akm Khyrul Wara; Kevin Croce; ShiYin Foo; Xinghui Sun; Basak Icli; Yevgenia Tesmenitsky; Fehim Esen; Anthony Rosenzweig; Mark W Feinberg
Journal: Blood Date: 2011-08-09 Impact factor: 22.113

10. Adenoviral-mediated endothelial precursor cell delivery of soluble CD115 suppresses human prostate cancer xenograft growth in mice.

Authors: Trevor Lucas; Dietmar Abraham; Gerold Untergasser; Karin Zins; Erhard Hofer; Eberhard Gunsilius; Seyedhossein Aharinejad
Journal: Stem Cells Date: 2009-09 Impact factor: 6.277